| CAS NO: | 1374248-81-3 |
| 规格: | ≥98% |
| 包装 | 价格(元) |
| 50mg | 电议 |
| 100mg | 电议 |
| 250mg | 电议 |
Atogepant (MK-8031; MK8031; Qulipta), a gepant, is a novel, oral and potent calcitonin gene-related peptide receptor antagonist approved in September 2021 for medical use in the United States to prevent episodic migraines.
纯度：≥98%
CAS：1374248-81-3
m.cnreagent.com